UMORE - Pharmacy

Luke Bereznicki

Luke Bereznicki

Assoc Prof Luke Bereznicki

Deputy Head, School of Medicine
Associate Head, Pharmacy
Associate Professor in Pharmacy Practice

BPharm (Hons) PhD MPS AACPA MAICD

Contact Details

Contact Campus Sandy Bay Campus
Building Pharmacy Building
Telephone +61 3 6226 2195
Fax +61 3 6226 2870
Email Luke.Bereznicki@utas.edu.au

Teaching Responsibilities

A/Prof Bereznicki commenced teaching at Pharmacy in 2007, and is now Associate Professor in Pharmacy Practice, Associate Head (Pharmacy) and Deputy Head of the School of Medicine. He teaches a diverse range of topics related to pharmacy practice including ethics, law, quality use of medicines, communication, non-prescription medicines and the identification and resolution of drug-related problems. He is also the Honours Co-ordinator.

Additional Information

A/Prof Bereznicki graduated from the University of Tasmania's Discipline of Pharmacy in 2002 with first class honours. In 2003, he was an inaugural recipient of a National Institute of Clinical Studies PhD Scholarship. His research program was focused on the implementation of strategies to improve the quality use of anticoagulants in the hospital and community settings. He was appointed at the University of Tasmania's Pharmacy in 2007 and is currently a Senior Lecturer in Pharmacy Practice. He is recognised as a leader in Australian pharmacy practice research and education, and has received a number of recent local and national awards recognising his work. He is dedicated to improving pharmacy practice in Australia through education, research and advocacy and was the 2008 Australian Young Pharmacist of the Year. In addition to his teaching and research activities, A/Prof Bereznicki is actively engaged in professional pharmacy practice; he works regularly in community pharmacy, writes regularly for the Australian Pharmacist and performs medication reviews and consultant pharmacist activities.

A/Prof Bereznicki's research has featured the implementation and evaluation of pharmacist involvement in a variety of quality improvement activities in both hospital and community settings. He is now recognised as one of the leading Australian authorities in this area and frequently speaks at conferences and provides education and training for health professionals and consumers. His research has been recognised nationally and internationally, and has resulted in a number of awards, including the following: Inaugural National Institute of Clinical Studies PhD Scholarship (2004-2007, Inaugural National Prescribing Service Student Quality Use of Medicine Award (2006), Tasmanian and Australian Pearcey Award for Innovative and Pioneering Achievement and Contribution to Research and Development in Information Technology (2006), Tasmanian Young Achiever in Science and Technology (2007) Dean of Graduate Research (University of Tasmania) Commendation for an outstanding doctoral thesis (2008) Pharmaceutical Society of Australia Young Pharmacist of the Year (2008) Faculty of Health, University of Tasmania Rising Star (2009) University of Tasmania Rising Star (2010)

Research Interests

A/Prof Bereznicki has been committed to improving the use and management of anticoagulants (such as warfarin) in Australia since his early career. Warfarin is a commonly used drug, particularly in the elderly, for stroke prevention. His work, therefore, has been focussed on strategies to improve the quality use of warfarin in the elderly via a range of innovative strategies. These projects have focussed on both the community dwelling and institutionalised elderly. He has published widely in local and international journals on this topic. His innovative research in anticoagulation management is internationally recognised and is currently being implemented to provide a unique, community-based, pharmacist-led service for all Australians (funding in the last 5 years exceeding $6.5M). He is also currently investigating the outcomes of warfarin therapy in elderly Australian veterans on behalf of the Department of Veterans Affairs. While research involving antithrombotic medications has been his major focus, A/Prof Bereznicki has also been involved in a number of other projects focussed on improving the quality use of medicines in community and hospital settings.

BPharm Hons thesis: An evaluation of the usefulness of portable INR monitors in rural Australian medical practice (Supervisor Professor Greg Peterson).

PhD thesis: Improving the quality use of anticoagulants in clinical practice (Supervisor Professor Greg Peterson).

A new focus for Luke is the implementation of evidence-based research in the hospital setting. He has already delivered a number of keynote addresses to pharmacists and doctors.

Research Areas

Clinical pharmacy and pharmacy practice:

  • Prevention and management of adverse drug reactions
  • Stroke prevention in atrial fibrillation
  • Monitoring of warfarin therapy
  • Management of respiratory disease